BetterScholar BetterScholar

P. Groeneveld

Clinical Infectious Diseases, British Journal of Clinical Pharmacology, Critical Care Medicine, Lancet. Infectious Diseases, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Antimicrobial Agents and Chemotherapy, Immunology, Cytokine, Immunobiology Show more
10
Role
Title
Level Year L/R
🐜 Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy
23 auth. A. Boerekamps, G. V. D. van den Berk, F. Lauw, E. Leyten, M. V. van Kasteren, A. van Eeden, D. Posthouwer, M. Claassen, A. Dofferhoff, D. Verhagen, ... W. Bierman, K. Lettinga, F. Kroon, C. Delsing, P. Groeneveld, R. Soetekouw, E. Peters, Sebastiaan J. Hullegie, S. Popping, D. A. van de Vijver, C. Boucher, J. Arends, B. Rijnders 		8 2018
8
🐜
🐜 Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism.
12 auth. D. Burger, I. P. van der heiden, C. L. la Porte, M. E. van der Ende, P. Groeneveld, C. Richter, ... P. Koopmans, F. Kroon, H. Sprenger, J. Lindemans, P. Schenk, R. V. van Schaik 		7 2006
7
🐜
🐬 Methylene blue increases myocardial function in septic shock.
Catharina R G Daemen-Gubbels, P. Groeneveld, A. Groeneveld, G. V. van Kamp, W. Bronsveld, L. Thijs 		7 1995
7
🐬
🐜 Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial.
14 auth. M. de Bruin, E. Oberjé, W. Viechtbauer, H. Nobel, M. Hiligsmann, C. van Nieuwkoop, J. Veenstra, F. Pijnappel, F. Kroon, L. van Zonneveld, ... P. Groeneveld, M. van Broekhuizen, S. Evers, J. Prins 		6 2017
6
🐜
🐜 Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014.
13 auth. M. Kraaij-Dirkzwager, A. Timen, K. Dirksen, L. Gelinck, E. Leyten, P. Groeneveld, C. Jansen, M. Jonges, Stalin V. Raj, I. Thurkow, ... R. V. Gageldonk-Lafeber, A. A. Eijk, M. Koopmans 		6 2014
6
🐜
🐬 Antibiotic-Induced Lipopolysaccharide (LPS) Release from Salmonella typhi: Delay between Killing by Ceftazidime and Imipenem and Release of LPS
P. van Langevelde, K. Kwappenberg, P. Groeneveld, H. Mattie, J. V. van Dissel 		5 1998
5
🐬
🦁 The differential effects of bacterial lipopolysaccharide (LPS) on splenic non-lymphoid cells demonstrated by monoclonal antibodies.
P. Groeneveld, T. Erich, G. Kraal 		5 1986
5
🦁
🦁 Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis.
P. Groeneveld, K. Kwappenberg, J. Langermans, P. Nibbering, L. Curtis 		5 1997
5
🦁
🐬 Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection.
A. Rachinger, Marjon Navis, S. van Assen, P. Groeneveld, H. Schuitemaker 		5 2008
5
🐬
🦁 In vivo effects of LPS on B lymphocyte subpopulations. Migration of marginal zone-lymphocytes and IgD-blast formation in the mouse spleen.
P. Groeneveld, T. Erich, G. Kraal 		5 1985
5
🦁